...the challenges of being of a CEO”, said Sandy Zweifach, co-founder and former CEO of Nuvelution Pharma Inc....
...changing roles, you go back to that,” she said. Karen Tkach Tuzman, Associate Editor Atlas Venture Venrock Agios Pharmaceuticals Inc. Nuvelution Pharma Inc. GammaDelta...

...NASDAQ:AFMD). Janpix Inc. appointed Sanford Zweifach as executive chairman. Zweifach was co-founder and CEO of Nuvelution Pharma Inc....
...Inc. (NASDAQ:GHDX) and Jaegar was the regional sales director for metabolics at AbbVie Inc. (NYSE:ABBV). Nuvelution Pharma Inc....
...director at Exagen Inc. (NASDAQ:XGN). BioCentury Staff Alector Inc. Translate Bio Inc. Janpix Inc. PMV Pharmaceuticals Inc. Canaan Kiadis Pharma N.V. Clarus Therapeutics Inc. Nuvelution Pharma Inc....

...Pa.) appointed Sanford Zweifach as the company’s first chairman. Zweifach is co-founder and CEO of Nuvelution Pharma Inc....

...interim CEO until a permanent replacement is found. She will also join the company’s board. Nuvelution Pharma Inc....

...is a founding investor in three risk-sharing companies: SFJ Pharmaceuticals Inc. , Avillion LLP and Nuvelution Pharma Inc....
...Avillion, last year closed a $105 million fund dedicated to risk-sharing investments. Virginia Li, Staff Writer Avillion LLP Nuvelution Pharma Inc. SFJ...

...Nuvelution Pharma Inc. , South San Francisco, Calif. Business: Finance Date announced: 2015-07-13 Note: Nuvelution Pharma Inc. debuted...

...Clarus Ventures' third disclosed risk-sharing start-up looks to be its broadest so far, as Nuvelution Pharma Inc. expects...